» Articles » PMID: 4402778

The Influence of Replacement of the N-ethyl Group by the Cyanoethyl Group on the Absorption, Distribution and Metabolism of (plus or Minus)-ethylamphetamine in Man

Overview
Specialties Pharmacology
Pharmacy
Date 1972 Mar 1
PMID 4402778
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

Safety and efficacy of fenproporex for obesity treatment: a systematic review.

Paumgartten F, Pereira S, Oliveira A Rev Saude Publica. 2016; 50:25.

PMID: 27253901 PMC: 4902098. DOI: 10.1590/S1518-8787.2016050006208.


Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices.

de la Torre R, Farre M, Navarro M, Pacifici R, Zuccaro P, Pichini S Clin Pharmacokinet. 2004; 43(3):157-85.

PMID: 14871155 DOI: 10.2165/00003088-200443030-00002.


N-(2-cyanoethyl)tranylcypromine, a potential prodrug of tranylcypromine: its disposition and interaction with catecholamine neurotransmitters in brain.

Nazarali A, Baker G, Coutts R, Wong T Pharm Res. 1987; 4(1):16-20.

PMID: 3508523 DOI: 10.1023/a:1016417624741.


Para-hydroxytranylcypromine: presence in rat brain and heart following administration of tranylcypromine and an N-cyanoethyl analogue.

Nazarali A, Baker G, Coutts R, Greenshaw A Eur J Drug Metab Pharmacokinet. 1987; 12(3):207-14.

PMID: 3436344 DOI: 10.1007/BF03189899.


Neuropharmacological and neurochemical properties of N-(2-cyanoethyl)-2-phenylethylamine, a prodrug of 2-phenylethylamine.

Baker G, Coutts R, Rao T Br J Pharmacol. 1987; 92(2):243-55.

PMID: 2890391 PMC: 1853650. DOI: 10.1111/j.1476-5381.1987.tb11318.x.